Bavarian Nordic A/S has received another vaccine contract from the US government, this time to develop candidate vaccine components and technologies for a combined smallpox and Marburg virus vaccine using the company’s vector technology. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
